APA (7th ed.) Citation

DE, E. A., DA, B., SM, R., MO, A., AA, E., LO, M., . . . H, H. (2025). Protective effect of valsartan alone and in combination with neprilysin inhibitor (valsartan + sacubitril) against hepatic ischemia-reperfusion injury: Targeting angiotensin II receptor-neprilysin and modulating SMAD-4/NF-κβ/JNK pathways in rats. Naunyn-Schmiedeberg's archives of pharmacology, 398(7), 8797. https://doi.org/10.1007/s00210-025-03820-w

Chicago Style (17th ed.) Citation

DE, Elsayed Abouzed, Bafail DA, Refaie SM, Aboelez MO, Elsayed AA, Mallasiy LO, Bayoumy NMK, and Hagar H. "Protective Effect of Valsartan Alone and in Combination with Neprilysin Inhibitor (valsartan + sacubitril) Against Hepatic Ischemia-reperfusion Injury: Targeting Angiotensin II Receptor-neprilysin and Modulating SMAD-4/NF-κβ/JNK Pathways in Rats." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 7 (2025): 8797. https://doi.org/10.1007/s00210-025-03820-w.

MLA (9th ed.) Citation

DE, Elsayed Abouzed, et al. "Protective Effect of Valsartan Alone and in Combination with Neprilysin Inhibitor (valsartan + sacubitril) Against Hepatic Ischemia-reperfusion Injury: Targeting Angiotensin II Receptor-neprilysin and Modulating SMAD-4/NF-κβ/JNK Pathways in Rats." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 7, 2025, p. 8797, https://doi.org/10.1007/s00210-025-03820-w.